Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-22 00:00:00 ET · period of report 2025-08-20 · accession 0001870913-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-08-22 | 2025-08-20+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $90.36 | -100.0K | 431.9K | -19% | -$9.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-20 | S | D | 47,012 | $90.27 | 484,908 | I Held by Esjay LLC | — | — | (F1) The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| 2 | Common | Common Stock | 2025-08-21 | S | D | 52,988 | $90.44 | 431,920 | I Held by Esjay LLC | — | — | (F3) The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |